Front Psychiatry. 2012;3:70. Epub 2012 Aug 7.

Transcutaneous Vagus Nerve Stimulation: Retrospective Assessment of Cardiac Safety in a Pilot Study.

Kreuzer PM, Landgrebe M, Husser O, Resch M, Schecklmann M, Geisreiter F, Poeppl TB, Prasser SJ, Hajak G, Langguth B.

Source

Department of Psychiatry and Psychotherapy, University of Regensburg Regensburg, Germany.

Abstract

Background: Vagus nerve stimulation has been successfully used as a treatment strategy for epilepsy and affective disorders for years. Transcutaneous vagus nerve stimulation (tVNS) is a new non-invasive method to stimulate the vagus nerve, which has been shown to modulate neuronal activity in distinct brain areas. Objectives: Here we report effects of tVNS on cardiac function from a pilot study, which was conducted to evaluate the feasibility and safety of tVNS for the treatment of chronic tinnitus. Methods: Twenty-four patients with chronic tinnitus underwent treatment with tVNS over 3-10 weeks in an open single-armed pilot study. Safety criteria and practical usability of the neurostimulating device were to investigate by clinical examination and electrocardiography at baseline and at several visits during and after tVNS treatment (week 2, 4, 8, 16, and 24). Results: Two adverse cardiac events (one classified as a severe adverse event) were registered but considered very unlikely to have been caused by the tVNS device. Retrospective analyses of electrocardiographic parameters revealed a trend toward shortening of the QRS complex after tVNS. Conclusion: To our knowledge this is one of the first studies investigating feasibility and safety of tVNS in a clinical sample. In those subjects with no known pre-existing cardiac pathology, preliminary data do not indicate arrhythmic effects of tVNS.

PMID:

22891061

[PubMed - as supplied by publisher]

http://www.ncbi.nlm.nih.gov/pubmed/22891061

Related citations in PubMed

• [A novel transcutaneous vagus nerve stimulation leads to brainstem and cerebral activations measured by functional MRI].[Biomed Tech (Berl). 2008]
  [A novel transcutaneous vagus nerve stimulation leads to brainstem and cerebral activations measured by functional MRI].

  Dietrich S, Smith J, Scherzinger C, Hofmann-Preiss K, Freitag T, Eisenkolb A, Ringler R. Biomed Tech (Berl). 2008 Jun; 53(3):104-11.
• Final Report on Carcinogens Background Document for Formaldehyde.[Rep Carcinog Backgr Doc. 2010]
  Final Report on Carcinogens Background Document for Formaldehyde.

  National Toxicology Program. Rep Carcinog Backgr Doc. 2010 Jan; (10-5981):i-512.
• Therapy of unspecific tinnitus without organic cause.[GMS Health Technol Assess. 2006]
  Therapy of unspecific tinnitus without organic cause.

  Frank W, Konta B, Seiler G. GMS Health Technol Assess. 2006 Aug 30; 2:Doc17. Epub 2006 Aug 30.
• Review An institutional experience with cervical vagus nerve trunk stimulation for medically refractory epilepsy: rationale, technique, and outcome.[Neurosurgery. 1998]
  Review An institutional experience with cervical vagus nerve trunk stimulation for medically refractory epilepsy: rationale, technique, and outcome.

  Amar AP, Heck CN, Levy ML, Smith T, DeGiorgio CM, Oviedo S, Apuzzo ML. Neurosurgery. 1998 Dec; 43(6):1265-76; discussion 1276-80.
• Review Modern management of epilepsy: Vagus nerve stimulation.[Baillieres Clin Neurol. 1996]
  Review Modern management of epilepsy: Vagus nerve stimulation.

  Ben-Menachem E. Baillieres Clin Neurol. 1996 Dec; 5(4):841-8.

See reviews...See all...